At Novartis, we are reimagining medicine
Behind the research driving our data
Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.
A decades-long journey in blood cancer research
Novartis immunologist describes the excitement of discovering a promising new immuno-oncology target in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome.
Accelerating our digital transformation with Amazon Web Services (AWS)
We are collaborating with AWS to build an enterprise-wide data and analytics platform to help transform business operations, starting with the way medicines are manufactured and delivered.